Skip to main content

Kundenmanagement in der Arzneimittelindustrie

  • Chapter
Management im Gesundheitswesen

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Bauer H, Keller T (2000) Arzneimittelversorgung in Gesundheitsnetzen. Pharma-Marketing Journal 25: 49–53

    Google Scholar 

  2. Becker H (1991) Kommunikations-Strategien im Pharma-Markt. Dissertation, Paderborn

    Google Scholar 

  3. Dallwig R (1996) Virtuelle Pharma-Unternehmen. Pharma-Marketing Journal 21: 58–67

    Google Scholar 

  4. EthicAd Inc. (2001) FAQ about DTC Advertising — Why is DTC advertising so controversial? Atlanta http://www.ethicad.org/consumer/advocate/faq.html#7, Zugriff am 22.10.2003

    Google Scholar 

  5. EUPHAMED Marketinggesellschaft für Medizin und Pharmazie. Der Pharmamarkt, Wiesbaden 1997

    Google Scholar 

  6. Flynn L (1999) Does ‘Direct-to-Consumer’ advertising of prescription drugs benefit the public’s health? Yes! Priorities for health 11(4): http://www.acsh.org/healthissues/news ID.669/healthissue_detail.asp

    Google Scholar 

  7. Harms F, Drüner M (2003) Pharmamarketing. Lucius & Lucius, Stuttgart

    Google Scholar 

  8. Henry J Kaiser Family Foundation (2001) Understanding the effects of direct-to-consumer prescription drug advertising. Menlo Park

    Google Scholar 

  9. Huh J, Becker L (2002) Direct-to-consumer prescription drug advertising: understanding its consequences. Athens

    Google Scholar 

  10. http://www.grady.uga.edu/coxcenter/activities/activities0203/docs/HuhBeckerforMaporfinal.pdf

    Google Scholar 

  11. Link M (2003) Der medikamentöse Schwangerschaftsabbruch mit Mifegyne. In: Dokumentation der Fachtagung Qualitätsstandards in der Schwangerschaftsabbruch-Versorgung im ersten Trimenon, Pro Familia für sexuelle und reproduktive Gesundheit und Rechte, S 35–41

    Google Scholar 

  12. Maag G (2000) Netzwerke, Gesundheitsmanagement und die Pharma-Industrie. Pharma-Marketing Journal 25: 101–106

    Google Scholar 

  13. Mair W, Kan M (2001) Direct-to-Consumer-Marketing (DTC-Marketing) — Was ist das?

    Google Scholar 

  14. englisch. htm, Zugriff am 05.01.2004

    Google Scholar 

  15. National Health Council (2002) Direct-to-Consumer Prescription Drug Advertising — Overview & Recommendations. Washington

    Google Scholar 

  16. Neslin S (2001) ROI Analysis of Pharmaceutical Promotion (RAPP): An Independent Study http://www.rxpromoroi.org/rapp/media/slides_speakernotes.pdf, Zugriff am 02.01.2004

    Google Scholar 

  17. O.V. (2002) Neue EU-Gesetzte geplant — Zum Wohl des Patienten oder aus finanziellem Interesse der Pharmaindustrie? VFA-Tagung am 19.04.2002, Berlin 2002[b] http://www.alzheimer-ethik.de/dtca.html, Zugriff am 22.12.2003

    Google Scholar 

  18. RMI (2000) DTC Advertising Can Enhance Public Health — The case for direct-to-consumer prescription medicine advertising, Researched Medicines Industry Association of New Zealand, Wellington http://www.rmianz.co.nz/html/views/briefing/extra.html, Zugriff am 26.12.2003

    Google Scholar 

  19. Saunders B (2003) Direct to consumer advertising of prescription drugs in New Zealand — Professors’ »Protest to Govern ment« placed under the microscope, Saunders Unsworth Limited, Wellington

    Google Scholar 

  20. Schotthöfer (2005) Recht im Marketing. Grundlagen, Fallbeispiele, Urteile. Verlagsgruppe Handelsblatt. Düsseldorf

    Google Scholar 

  21. Spickschen J, Crisand M (1999) Disease Management: Eine Chance für die Pharma-Industrie. Pharma-Marketing Journal 24: 82–87

    Google Scholar 

  22. Streuli R (2002) Patient empowerment — falsch verstanden. Schweiz Med Forum Nr. 45, November 2002, http://www.medicalforum.ch/pdf_d/2002/2002-45/2002-45-459.PDF, Zugriff am 25.12.2003

    Google Scholar 

  23. Verband Forschender Arzneimittelhersteller (VFA) 2000

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Mayer, L.A., Trommsdorff, V. (2006). Kundenmanagement in der Arzneimittelindustrie. In: Busse, R., Schreyögg, J., Gericke, C. (eds) Management im Gesundheitswesen. Springer, Berlin, Heidelberg . https://doi.org/10.1007/978-3-540-29465-8_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-29465-8_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-29463-4

  • Online ISBN: 978-3-540-29465-8

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics